In Brief: Selfcare, Inc.
This article was originally published in The Gray Sheet
Executive Summary
Acquires diabetes care product supplier Can-Am Care for approximately $27 mil., including $13.6 mil. in cash, a $2 mil. note and about 1.1 mil. shares of Selfcare common stock. Can-Am, which markets insulin syringes, blood lancets, glucose tablets and specialty skin creams to pharmacies nationwide, generated approximately $25 mil. in revenues in fiscal 1997. Selfcare, which makes health maintenance and home self-test diagnostic products for the diabetes, women's health and nutritional supplement markets, calls the acquisition "an excellent fit with the rest of Selfcare's business" and anticipates "good opportunities to increase our total shelf space in pharmacies where our products are sold." The acquisition is expected to be accretive to earnings...